Access

News and Views

Nature 435, 577-579 (2 June 2005) | doi:10.1038/435577a; Published online 1 June 2005

Open Innovation Challenges

Gene therapy:  The moving finger

Katherine A. High1

Top

DNA-cleaving enzymes trigger a repair process that can now be harnessed to correct mutations in the human genome in vitro. This represents another step towards gene-correction strategies for treating human disease.

Genetic engineering and gene-transfer technologies have produced a wealth of new ideas about how to treat genetic diseases. Many of these have been applied quite successfully in cultured cells and even in mouse models of human disease, but have proven remarkably difficult to translate into clinical practice.

  1. Katherine A. High is at The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA.
    Email: high@email.chop.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

'Magic' scissors for genome surgery

Nature Biotechnology News and Views (01 Jun 2005)

Targeted mutagenesis in zebrafish

Nature Biotechnology News and Views (01 Jun 2008)

See all 6 matches for News And Views